Document is current
Any future updates will be listed below
-
Authors
El Ouardi, Najlae https://orcid.org/0000-0003-1228-391X
Hmamouchi, Ihsane https://orcid.org/0000-0003-4402-5034
Abouqal, Redouane
Allali, Fadoua
Bahiri, Rachid
El Bouchti, Imane
Ghozlani, Imad https://orcid.org/0000-0001-7966-4173
Hassikou, Hasna
Ichchou, Linda https://orcid.org/0000-0002-2733-5594
Janani, Saadia
Harzy, Taoufik
Niamane, Radouane https://orcid.org/0000-0002-0472-2532
Bezza, Ahmed https://orcid.org/0000-0003-3788-7146
El Maghraoui, Abdellah https://orcid.org/0000-0003-0668-5680
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 5 May 2025
First Online: 27 May 2025
Declarations
:
: This project was approved by the ethics committee for biomedical research of Faculty of Medicine, Mohammed V. Rabat. Morocco (approval number: A-RS-308/2017). This study is conducted based on the ethical spirit of the “Declaration of Helsinki”. All involved participants provided written informed consent.
: Not applicable.
: N EO and RA: None. IH: Support for meeting attendance from Pfizer, Novartis, Sothema. FA: Lecture honoraria from Pfizer, Abbvie, Bottu, Cooper, Sothema, Support for meeting attendance from Pfizer, Janssen, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Abbvie. RB: Lecture honoraria from Pfizer, Abbvie, Bottu, Cooper, Sothema, Janssen, Novartis, Hikma, Newbridge, Support for meeting attendance from Pfizer, Janssen, Newbridge, Cooper, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Abbvie. EB I: Lecture honoraria from Pfizer, Abbvie, Bottu, Cooper, janssen, novartis, Support for meeting attendance from Pfizer, Janssen, abbvie, hikma, sothema. I EG: Lecture honoraria from Pfizer, Abbvie, Novartis, Sothema, Cooper, Support for meeting attendance from Pfizer, Roche, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Janssen, NewBridge Pharmaceuticals. HH: Lecture honoraria from Pfizer, Abbvie, Novartis, Sothema, Cooper, Support for meeting attendance from Pfizer, Roche, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Janssen, NewBridge Pharmaceuticals. LI: Lecture honoraria from Pfizer, Bottu, Phi. SJ: None. HT: Lecture honoraria from Abbvie, Bottu, Sothema, Janssen, Support for meeting attendance from Pfizer, Sothema, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, NewBridge pharmaceuticals, Abbvie, Novartis. RN: Lecture honoraria from Pfizer, Abbvie, Bottu, Jenssen, Sothema, Support for meeting attendance from Pfizer, Janssen, Roche, Participation on a Data Safety Monitoring Board or Advisory Board from Pfizer, Abbvie, Jenssen, Sothema, NewBridge. AB:: Lecture honoraria from Pfizer, Abbvie, Bottu, Cooper, Sothema, Support for meeting attendance from Pfizer, Janssen, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Abbvie. A EM: Lecture honoraria from Pfizer, Abbvie, Bottu, Cooper, Sothema, Support for meeting attendance from Pfizer, Janssen, Participation on a Data Safety Monitoring Board or Advisory Board from Sothema, Pfizer, Abbvie.
